ACAD
40.19
-0.63
-1.54%
AEMD
8.74
+0.11
+1.27%
APRI
1.64
+0.02
+1.23%
ARNA
3.985
-0.025
-0.623%
ATEC
1.36
0.00
0.00%
CNAT
5.46
+0.11
+2.06%
CRXM
0.49
+0.02
+5.15%
CYTX
0.732
+0.043
+6.1956%
DXCM
71.27
-0.37
-0.52%
GNMK
9.37
+0.11
+1.19%
HALO
17.68
-0.14
-0.79%
ILMN
208.62
-0.85
-0.41%
INNV
0.153
+0.003
+1.6667%
INO
8.58
+0.19
+2.26%
ISCO
0.05
0.00
0.00%
ISIS
66.71
-1.01
-1.49%
LGND
88.15
+0.89
+1.02%
LPTN
0.291
-0.009
-3.032%
MBVX
2.26
-0.08
-3.42%
MEIP
1.89
-0.02
-1.05%
MNOV
3.95
0.00
0.00%
MRTX
36.18
+2.43
+7.20%
MSTX
0.54
+0.03
+5.70%
NBIX
42.76
-0.18
-0.42%
NUVA
49.62
+0.84
+1.72%
ONCS
0.233
0.00
0.00%
ONVO
4.96
+0.17
+3.55%
OREX
4.92
-0.01
-0.20%
OTIC
24.33
-0.13
-0.53%
QDEL
22.24
-0.17
-0.76%
RCPT
164.83
-0.82
-0.50%
RGLS
13.58
-0.05
-0.37%
RMD
58.65
+0.55
+0.95%
SCIE
0.018
0.00
0.00%
SPHS
1.11
+0.03
+2.78%
SRNE
13.8
+0.76
+5.83%
TROV
11
-0.19
-1.70%
VICL
0.955
+0.033
+3.534%
VOLC
17.99
0.00
0.00%
ZGNX
1.49
+0.02
+1.36%
ACAD
40.19
-0.63
-1.54%
AEMD
8.74
+0.11
+1.27%
APRI
1.64
+0.02
+1.23%
ARNA
3.985
-0.025
-0.623%
ATEC
1.36
0.00
0.00%
CNAT
5.46
+0.11
+2.06%
CRXM
0.49
+0.02
+5.15%
CYTX
0.732
+0.043
+6.1956%
DXCM
71.27
-0.37
-0.52%
GNMK
9.37
+0.11
+1.19%
HALO
17.68
-0.14
-0.79%
ILMN
208.62
-0.85
-0.41%
INNV
0.153
+0.003
+1.6667%
INO
8.58
+0.19
+2.26%
ISCO
0.05
0.00
0.00%
ISIS
66.71
-1.01
-1.49%
LGND
88.15
+0.89
+1.02%
LPTN
0.291
-0.009
-3.032%
MBVX
2.26
-0.08
-3.42%
MEIP
1.89
-0.02
-1.05%
MNOV
3.95
0.00
0.00%
MRTX
36.18
+2.43
+7.20%
MSTX
0.54
+0.03
+5.70%
NBIX
42.76
-0.18
-0.42%
NUVA
49.62
+0.84
+1.72%
ONCS
0.233
0.00
0.00%
ONVO
4.96
+0.17
+3.55%
OREX
4.92
-0.01
-0.20%
OTIC
24.33
-0.13
-0.53%
QDEL
22.24
-0.17
-0.76%
RCPT
164.83
-0.82
-0.50%
RGLS
13.58
-0.05
-0.37%
RMD
58.65
+0.55
+0.95%
SCIE
0.018
0.00
0.00%
SPHS
1.11
+0.03
+2.78%
SRNE
13.8
+0.76
+5.83%
TROV
11
-0.19
-1.70%
VICL
0.955
+0.033
+3.534%
VOLC
17.99
0.00
0.00%
ZGNX
1.49
+0.02
+1.36%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.